144,000
Participants
Start Date
January 2, 2019
Primary Completion Date
January 17, 2023
Study Completion Date
January 17, 2023
Rifampicin
Rifampicin will be given in the same way to arms 2, 3 and 4 (weight dependent). Only the strategy of whom to offer PEP differs between the arms.
Damien Foundation, Anjouan
Damien Foundation, Mohéli
Fondation Raoul Follereau, Miandrivazo
Collaborators (1)
Damien Foundation
OTHER
Centre d'Infectiologie Charles Mérieux
OTHER
Fondation Raoul Follereau
UNKNOWN
Leiden University Medical Center
OTHER
L'Institut National de la Santé et de la Recherche Médicale
UNKNOWN
Genoscreen
OTHER
Instituto Fernandes Figueira
OTHER_GOV
Institute of Tropical Medicine, Belgium
OTHER